Featured Editorial
Patient Centricity And Social Media Are Changing Patient Recruitment
By Ed Miseta, chief editor, Clinical Leader

Thirty years ago, patient recruitment was a challenge for pharma companies. Today, the patient participation rate in trials still hovers around five percent and is not expected to improve anytime soon. Patient recruitment remains a challenge that pharma must work to overcome.  

Industry Insights
Investigator Site Turnover: The Importance Of CRO Support
Article | By Dave Espenshade, Greenphire

How to offer superior value-add by enhancing a site’s clinical trial experience for improved outcomes, strengthening the relationship, and positioning sites for future trial success.

eCOA Resources Overview
Article | By Jackie Brusch, CRF Health, a CRF Bracket Company

Access to electronic clinical outcome assessment (eCOA) resources from the past twelve months.

Ensuring Robust ePRO Implementation: Factors For Success
Article | By Jonathan Pritchard, Cytel

In this blog, Jonathan Pritchard, director of business development at Cytel, draws on his experience in commercial, clinical, and technology roles within the biopharmaceutical industry and shares his insights on the primary considerations for sponsors when implementing an ePRO solution.

From Laboratory To Bedside: Expediting Development Of Novel Rare Cancer Treatments
Webinar | Premier Research

This webinar shares new insights on rare oncology drug development and examines how new processes and regulatory pathways are helping speed development of novel therapies.

Pharmacoeconomic Assessment Through Market Approval And Beyond: Theory And Operations
Webinar | Medpace

Pharmacoeconomic assessment of a drug, medical device, or other healthcare product can take on many forms and occur at multiple points in the development cycle. Join Medpace experts as they explore the application of pharmacoeconomic assessment throughout all phases of clinical trials as well as in observational studies, including registries and other post-marketing data collection.

Addressing Acceptable Recruitment Methods For Clinical Trial Sponsors And Sites
Webinar | WCG

Patient engagement solutions to expedite study recruitment.


The 4th annual IO Combinations 360° program addresses business aspects, clinical advancements, and scientific data in IO combination strategies. The rapid advancement in our understanding of human cancer immunity and immunotherapy combinations is nearly impossible for individual scientists to comprehend. Only together, as an engaged scientific community, can we hope to enable a patient’s immune system to eradicate cancer.

For more information, click here.

Life Science Leader Magazine

Have you heard of Life Science Leader?
Check it out today for access to candid interviews with top-tier executives on how they do business.

Connect With Clinical Leader:
   LinkedIn    Twitter